About Caplin Steriles
Caplin Steriles is a company based in Chennai (India) founded in 2019. Caplin Steriles has raised $30.65 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 1,003 employees as of April 05, 2024. Caplin Steriles offers products and services including Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and Ropivacaine Hydrochloride Injection.
- Headquarter Chennai, India
- Employees 1003 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Caplin Steriles Limited
- Date of Incorporation 12 Dec, 2018
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$25.66 M (USD)66.98as on Mar 31, 2023
-
Net Profit
$89.12 K (USD)103.05as on Mar 31, 2023
-
EBITDA
$1.7 M (USD)176.78as on Mar 31, 2023
-
Total Equity Funding
$30.65 M (USD)
in 1 rounds
-
Latest Funding Round
$30.65 M (USD), Series C
Jan 19, 2019
-
Investors
Eight Roads Ventures
& 1 more
-
Employee Count
1003
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Caplin Steriles
Caplin Steriles offers a comprehensive portfolio of products and services, including Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and Ropivacaine Hydrochloride Injection.
Medical injection for treating nasal congestion and hypotension.
Injection used for reducing secretions in surgical procedures.
Injection for managing hypertensive emergencies and heart failure.
Injection to treat arrhythmias and high blood pressure.
Local anesthetic injection for pain management during surgery.
Injection to prevent bleeding in surgical and traumatic situations.
Funding Insights of Caplin Steriles
Caplin Steriles has successfully raised a total of $30.65M through 1 strategic funding round. The most recent funding activity was a Series C round of $30.65 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $30.6M
-
First Round
First Round
(19 Jan 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series C - Caplin Steriles | Valuation | Eight Roads Ventures , F-Prime Capital |
|
Investors in Caplin Steriles
Caplin Steriles has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Caplin Steriles
Financial Statements - Caplin Steriles
Caplin Steriles Comparisons
Competitors of Caplin Steriles
Frequently Asked Questions about Caplin Steriles
Caplin Steriles was founded in 2019.
Caplin Steriles is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Caplin Steriles is a funded company, having raised a total of $30.65M across 1 funding round to date. The company's 1st funding round was a Series C of $30.65M, raised on Jan 19, 2019.
As of Apr 05, 2024, the latest employee count at Caplin Steriles is 1,003.
Annual revenue of Caplin Steriles is $25.66M as on Mar 31, 2023.
Caplin Steriles was founded in 2019 and is based in Chennai, India. Operations are centered in the pharmaceutical sector, where injectable products are developed and manufactured. Focus is placed on vials, lyophilized vials, and ophthalmic drops. The company maintains a domain at caplinsteriles.net for its activities, supporting production in this specialized field.
Caplin Steriles offers Phenylephrine HCL Injection, Glycopyrrolate Injection, Sodium Nitroprusside Injection, Verapamil Hydrochloride Injection, and 2 more products and services.
Caplin Steriles has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.